|
End-of-day quote
Moscow Micex - RTS
08/07/2022
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 1.36B 115B 1.21B 1.13B 1.03B 1.93B 131B 1.95B 13.62B 5.3B 66.66B 5.09B 4.98B 214B | P/E 2021 |
-2.42x | P/E 2022 | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 178B 1.87B 1.74B 1.58B 2.98B 202B 3B 21.01B 8.17B 103B 7.85B 7.68B 331B | EV / Sales 2021 |
5.43x | EV / Sales 2022 | 5.51x |
| Free-Float |
95.22% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +10.15% |
| 5 years | 2.64 |  | 7 |
| 10 years | 2.64 | | 18.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 01/01/2014 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dmitriy Genkin
CHM | Chairman | 57 | 01/01/2005 |
| Director/Board Member | 58 | - | |
Alexey Shafranov
BRD | Director/Board Member | 47 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.15% | -.--% | -.--% | -.--% | 25.27M | |
| +0.02% | -3.41% | +36.11% | +115.09% | 1,019B | |
| -1.21% | -6.74% | +34.08% | +62.64% | 617B | |
| +1.12% | +0.54% | +13.62% | +79.94% | 464B | |
| -3.30% | -6.21% | +56.45% | +36.58% | 356B | |
| +0.93% | -3.16% | +21.65% | +43.02% | 333B | |
| +0.12% | -2.77% | +10.70% | +32.97% | 267B | |
| -0.89% | -6.28% | -7.00% | +8.01% | 244B | |
| -0.01% | -2.81% | +35.28% | +51.82% | 218B | |
| -0.08% | -4.17% | +28.34% | +93.51% | 179B | |
| Average | +0.33% | -2.17% | +22.92% | +52.36% | 369.72B | |
| Weighted average by Cap. | -0.51% | -3.54% | +28.50% | +70.11% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 438M 37.29B 391M 364M 332M 624M 42.21B 629M 4.4B 1.71B 21.55B 1.65B 1.61B 69.25B | 380M 32.3B 339M 316M 287M 541M 36.56B 545M 3.81B 1.48B 18.66B 1.43B 1.39B 59.99B |
| Net income | -698M -59.34B -622M -580M -528M -994M -67.18B -1B -7.01B -2.73B -34.29B -2.62B -2.56B -110B | -207M -17.65B -185M -172M -157M -296M -19.98B -298M -2.08B -811M -10.2B -779M -762M -32.78B |
| Net Debt | 693M 58.95B 618M 576M 524M 987M 66.73B 994M 6.96B 2.71B 34.06B 2.6B 2.55B 109B | 736M 62.63B 657M 612M 557M 1.05B 70.9B 1.06B 7.39B 2.88B 36.19B 2.76B 2.7B 116B |
Employees
59
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
